In the authors' words

“HIIT is feasible, safe, and seems to promote greater improvements in CRF compared with MICT and UC in women at high risk for breast cancer.”

What was measured

About the study

Type
Randomised trial
Who took part
Postmenopausal, breast cancer survivors, overweight or obesity
How many
44
How long
12 weeks
Exercise
High-intensity intervals, Other aerobic exercise
Cited
11 times, per Europe PMC
PubMed ID
31269007

How to read this. Each line is one study, summarised in plain language from its PubMed abstract, with the authors' own sentence underneath on the study page. A count of studies is not a verdict: trials differ in size, length and quality, and a result in one group of women may not hold in another. Nothing here is medical advice.

Summaries are generated, then checked by machine against the abstract they came from; any summary that could not be matched word for word was left out. Our clinical lead is reviewing the summaries topic by topic, and this note will change when that is done. Corpus last refreshed 2026-11-03. Spotted a mistake? Tell us and we will fix the summary or remove the study.

Similar studies